4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000080
EVP, Chf Clinical Develop Ofcr sold 1,484 shares at $32.20 ($47,780)
- EVP, Chf Clinical Develop Ofcr acquired 4,032 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schneider Eugene · EVP, Chf Clinical Develop Ofcr
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-30 | Grant or award : show line 1 in the form | +4,032 | 62,540 | D | ||
| 2025-01-31 | Sale : show line 2 in the form | −1,484 | $32.20 | $47,780 | 61,056 | D |
| Open-market sales · 1,484 sh · avg $32.20 · $47,780 | ||||||
Loading xslF345X05/edgardoc.xml…